cliexa, an AI-powered clinical intelligence company, and OpiSafe, a leader in opioid prescribing, monitoring, and stewardship technologies, today announced a strategic partnership to deliver a next-generation behavioral health medication management platform designed for health systems, payers, government agencies, and provider organizations.
This partnership will launch the industry’s most comprehensive solution for identifying risk, supporting evidence-based interventions, and improving access to behavioral health and addiction treatment services. This reflects a broader industry shift toward interoperable clinical intelligence ecosystems, where predictive analytics, clinical decision support, patient engagement, and care coordination technologies operate together within existing healthcare workflows.
As healthcare organizations continue to face challenges related to opioid misuse, chronic pain management, regulatory compliance, and behavioral health access, the combined platform provides clinicians with actionable intelligence and guided workflows directly within existing electronic medical record (EMR) systems.